Showing results (7131-7140 of 45,234) with videos related to
Sort By:
Pageof 4,524
Cancer Research|November 1, 1975
Diminished binding of thyroid-stimulating hormone in a transplantable rat thyroid tumor as a possible cause of hormone unresponsivenessE Mandato, M F Meldolesi, V MacchiaCancer Research|November 1, 1975
The tissue culture and morphology of human breast tumor cell line BOT-2R E Nordquist, D R Ishmael, C A Lovig, et al.Cancer Research|November 1, 1975
Some biochemical characteristics of rat liver and Morris hepatoma nuclei and nuclear membranesM Spangler, M L Coetzee, S L Katyal, et al.Cancer Research|November 1, 1975
Pathological review of breast lesions analyzed for estrogen receptor proteinP P Rosen, C J Menendez-Botet, J S Nisselbaum, et al.Cancer Research|July 15, 1991
Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptorR Yabkowitz, V M DixitCancer Research|July 25, 1991
Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblastsH Ford, D A Cooney, G S Ahluwalia, et al.Cancer Research|September 20, 2006
Interplay between Notch signaling and epigenetic silencers in cancerMaria DominguezCancer Research|September 20, 2006
Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomasLeonardo A Meza-Zepeda, Stine H Kresse, Ana H Barragan-Polania, et al.Cancer Research|September 20, 2006
Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activationStéphanie Gout, Chantale Morin, François Houle, et al.Cancer Research|September 20, 2006
KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular propertiesKazuhide Nakamura, Eri Taguchi, Toru Miura, et al.Pageof 4,524